NASDAQ:APTX

Aptinyx News Headlines

$3.50
+0.29 (+9.03 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.38
$4.73
50-Day Range
$2.39
$3.50
52-Week Range
$2.30
$6.47
Volume28.89 million shs
Average Volume808,782 shs
Market Capitalization$238.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.36

Aptinyx (NASDAQ APTX) News Headlines Today

SourceHeadline
Head to Head Analysis: Ardelyx (NASDAQ:ARDX) vs. Aptinyx (NASDAQ:APTX)Head to Head Analysis: Ardelyx (NASDAQ:ARDX) vs. Aptinyx (NASDAQ:APTX)
americanbankingnews.com - June 11 at 11:40 AM
2 “Strong Buy” Penny Stocks That Could Rally to $10 (or More) - Nasdaq2 “Strong Buy” Penny Stocks That Could Rally to $10 (or More) - Nasdaq
nasdaq.com - June 10 at 8:12 PM
Investors Buy Large Volume of Call Options on Aptinyx (NASDAQ:APTX)Investors Buy Large Volume of Call Options on Aptinyx (NASDAQ:APTX)
americanbankingnews.com - June 10 at 7:02 PM
Zacks: Analysts Anticipate Aptinyx Inc. (NASDAQ:APTX) to Post -$0.26 EPSZacks: Analysts Anticipate Aptinyx Inc. (NASDAQ:APTX) to Post -$0.26 EPS
americanbankingnews.com - June 9 at 5:17 PM
Companies Like Aptinyx (NASDAQ:APTX) Are In A Position To Invest In Growth - NasdaqCompanies Like Aptinyx (NASDAQ:APTX) Are In A Position To Invest In Growth - Nasdaq
nasdaq.com - June 6 at 2:45 PM
Aptinyx Inc. (NASDAQ:APTX) Expected to Post Earnings of -$0.26 Per ShareAptinyx Inc. (NASDAQ:APTX) Expected to Post Earnings of -$0.26 Per Share
americanbankingnews.com - May 22 at 2:14 AM
Aptinyx Inc. (NASDAQ:APTX) Receives Average Recommendation of "Buy" from BrokeragesAptinyx Inc. (NASDAQ:APTX) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - May 20 at 2:10 AM
Form 4 Aptinyx Inc. For: May 17 Filed by: KHANNA ASHISH - StreetInsider.comForm 4 Aptinyx Inc. For: May 17 Filed by: KHANNA ASHISH - StreetInsider.com
streetinsider.com - May 19 at 10:50 PM
Form 4 Aptinyx Inc. For: May 17 Filed by: KIDD ANDREW - StreetInsider.comForm 4 Aptinyx Inc. For: May 17 Filed by: KIDD ANDREW - StreetInsider.com
streetinsider.com - May 19 at 10:50 PM
Aptinyx Reports First Quarter 2021 Financial Results and Highlights - Business WireAptinyx Reports First Quarter 2021 Financial Results and Highlights - Business Wire
businesswire.com - May 15 at 10:31 AM
Aptinyx Inc. (APTX) Q1 2021 Earnings Call TranscriptAptinyx Inc. (APTX) Q1 2021 Earnings Call Transcript
fool.com - May 14 at 5:45 AM
Aptinyx Reports First Quarter 2021 Financial Results and Highlights - Yahoo FinanceAptinyx Reports First Quarter 2021 Financial Results and Highlights - Yahoo Finance
finance.yahoo.com - May 14 at 2:29 AM
Aptinyx Reports First Quarter 2021 Financial Results and HighlightsAptinyx Reports First Quarter 2021 Financial Results and Highlights
finance.yahoo.com - May 14 at 2:29 AM
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors - Business WireAptinyx Appoints Joan W. Miller, M.D. to Board of Directors - Business Wire
businesswire.com - May 10 at 9:09 PM
Aptinyx Appoints Joan W. Miller, M.D. to Board of DirectorsAptinyx Appoints Joan W. Miller, M.D. to Board of Directors
finance.yahoo.com - May 10 at 4:09 PM
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021 - Business WireAptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021 - Business Wire
businesswire.com - April 29 at 8:25 PM
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
finance.yahoo.com - April 29 at 8:25 PM
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting - Yahoo FinanceAptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting - Yahoo Finance
finance.yahoo.com - April 29 at 3:25 PM
World Antidepressants Market Growth to 2030 and COVID-19 Implications - Yahoo FinanceWorld Antidepressants Market Growth to 2030 and COVID-19 Implications - Yahoo Finance
finance.yahoo.com - April 29 at 10:25 AM
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting - Business WireAptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting - Business Wire
businesswire.com - April 29 at 10:25 AM
Aptinyx to Participate in Upcoming ConferencesAptinyx to Participate in Upcoming Conferences
finance.yahoo.com - April 27 at 9:42 AM
Global Antidepressants Market Report 2021: COVID-19 Causes a Surge in Demand for Antidepressant Drugs as Mental Health Problems Rise - ResearchAndMarkets.com - Business WireGlobal Antidepressants Market Report 2021: COVID-19 Causes a Surge in Demand for Antidepressant Drugs as Mental Health Problems Rise - ResearchAndMarkets.com - Business Wire
businesswire.com - April 26 at 8:42 AM
Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning - Investorplace.comToday’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning - Investorplace.com
investorplace.com - April 21 at 7:52 AM
Is AquaBounty Technologies, Inc.s (NASDAQ:AQB) Shareholder Ownership Skewed Towards Insiders? - NasdaqIs AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shareholder Ownership Skewed Towards Insiders? - Nasdaq
nasdaq.com - April 8 at 5:24 AM
What Kind Of Shareholders Hold The Majority In Aptinyx Inc.s (NASDAQ:APTX) Shares? - NasdaqWhat Kind Of Shareholders Hold The Majority In Aptinyx Inc.'s (NASDAQ:APTX) Shares? - Nasdaq
nasdaq.com - April 7 at 12:31 PM
Aptinyx (APTX) Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinsons Disease Dementia and Dementia with Lewy Bodies - StreetInsider.comAptinyx (APTX) Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson's Disease Dementia and Dementia with Lewy Bodies - StreetInsider.com
streetinsider.com - April 6 at 9:26 PM
Aptinyx shares gain after resuming mid-stage study of NYX-458 in cognitive impairment - Seeking AlphaAptinyx shares gain after resuming mid-stage study of NYX-458 in cognitive impairment - Seeking Alpha
seekingalpha.com - April 6 at 4:25 PM
Aptinyx Stock Is Trading Higher After Restarting NYX-458 Study In Dementia Associated Cognitive Impairment - BenzingaAptinyx Stock Is Trading Higher After Restarting NYX-458 Study In Dementia Associated Cognitive Impairment - Benzinga
benzinga.com - April 6 at 4:25 PM
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinsons Disease Dementia and Dementia with Lewy Bodies - Business WireAptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson's Disease Dementia and Dementia with Lewy Bodies - Business Wire
businesswire.com - April 6 at 11:24 AM
Aptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy BodiesAptinyx Recommences Phase 2 Study of NYX-458 in Patients with Cognitive Impairment Associated with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
finance.yahoo.com - April 6 at 11:24 AM
Aptinyx (NASDAQ:APTX) Shareholders Have Enjoyed A 32% Share Price Gain - Yahoo FinanceAptinyx (NASDAQ:APTX) Shareholders Have Enjoyed A 32% Share Price Gain - Yahoo Finance
finance.yahoo.com - March 31 at 10:05 AM
Aptinyx (NASDAQ:APTX) Shareholders Have Enjoyed A 32% Share Price GainAptinyx (NASDAQ:APTX) Shareholders Have Enjoyed A 32% Share Price Gain
finance.yahoo.com - March 31 at 10:05 AM
Ocugen Looks Very Dicey at Current Levels - NasdaqOcugen Looks Very Dicey at Current Levels - Nasdaq
nasdaq.com - March 25 at 10:25 PM
Aptinyx Inc. 2020 Q4 - Results - Earnings Call PresentationAptinyx Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 25 at 9:55 PM
Jefferies Financial Group Q1 Profit Rises - NasdaqJefferies Financial Group Q1 Profit Rises - Nasdaq
nasdaq.com - March 25 at 7:18 AM
Aptinyx: Q4 Earnings Insights - Yahoo FinanceAptinyx: Q4 Earnings Insights - Yahoo Finance
finance.yahoo.com - March 25 at 7:18 AM
Aptinyx: Q4 Earnings Insights - BenzingaAptinyx: Q4 Earnings Insights - Benzinga
benzinga.com - March 25 at 1:55 AM
Aptinyx Inc. (APTX) Q4 2020 Earnings Call TranscriptAptinyx Inc. (APTX) Q4 2020 Earnings Call Transcript
finance.yahoo.com - March 25 at 1:55 AM
Aptinyx: Q4 Earnings InsightsAptinyx: Q4 Earnings Insights
finance.yahoo.com - March 24 at 8:54 PM
Aptinyx Inc. (APTX) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseAptinyx Inc. (APTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - March 17 at 5:15 PM
Aptinyx Inc.(APTX)Aptinyx Inc.(APTX)
fool.com - March 14 at 9:11 AM
Fibromyalgia Treatment Market to Reach USD 1,414.4 Million by 2027; Increasing Investments in R&D for Pain Management Therapies to Bolster Growth, states Fortune Business Insights™ - Yahoo FinanceFibromyalgia Treatment Market to Reach USD 1,414.4 Million by 2027; Increasing Investments in R&D for Pain Management Therapies to Bolster Growth, states Fortune Business Insights™ - Yahoo Finance
finance.yahoo.com - March 9 at 7:42 AM
WOOF Sep 2021 12.500 putWOOF Sep 2021 12.500 put
ca.finance.yahoo.com - March 4 at 12:57 AM
WOOF Jun 2021 15.000 putWOOF Jun 2021 15.000 put
ca.finance.yahoo.com - March 4 at 12:57 AM
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021 - Business WireAptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021 - Business Wire
businesswire.com - March 2 at 5:52 PM
Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021Aptinyx to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021
finance.yahoo.com - March 2 at 12:51 PM
Aptinyx to Participate in Upcoming Investor Conferences - Business WireAptinyx to Participate in Upcoming Investor Conferences - Business Wire
businesswire.com - February 22 at 9:37 AM
Aptinyx to Participate in Upcoming Investor ConferencesAptinyx to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 22 at 9:37 AM
Aptinyx: An Overdue Reassessment - Seeking AlphaAptinyx: An Overdue Reassessment - Seeking Alpha
seekingalpha.com - February 17 at 7:22 PM
Aptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference - Yahoo FinanceAptinyx to Participate at 10th Annual SVB Leerink Global Healthcare Conference - Yahoo Finance
finance.yahoo.com - February 11 at 3:21 PM
This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.